Meanwhile, significantly lower levels of LRFN5 and OLFM4 in the DT-MDD group than in the DN-MDD group were found, which indicated that their levels might be partially reversed by antidepressant therapy. The gene discussed is LRFN5; the disease is major depressive disorder.